OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Posting of Annual Report and confirmation of AGM
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, confirms that the Notice of Annual General Meeting ('AGM') along with the Annual Report and Accounts for the year ended 31 March 2022 has been posted to shareholders yesterday afternoon and will shortly be made available on the Company's website at:
As previously announced, the AGM of the Company will be held on Wednesday 26 October 2022 at 11.00am at Poets House, St Mary's Street, Ely, CB7 4EY.
Contacts:
| Omega Diagnostics Group PLC | |||
| Jag Grewal, Chief Executive Officer | via Walbrook PR | ||
| Chris Lea, Chief Financial Officer | | ||
| | | ||
| finnCap Ltd | Tel: 020 7220 0500 | ||
| Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) | | ||
| Alice Lane/Charlotte Sutcliffe (ECM) | | ||
| | | ||
| Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com | ||
| Paul McManus / Sam Allen / Lianne Applegarth | Mob: 07980 541 893 / 07502 558 258 / 07584 391 303 | ||
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.